Yuta Okamura

Plasmid-based and -free methods using CRISPR/Cas9 system for replacement of targeted genes in Colletotrichum sansevieriae

Masayuki Nakamura, Yuta Okamura, Hisashi Iwai · Scientific Reports · 2019 · 29 citations · Full text

Synthesis of 4-Alkylidene-4<i>H</i>-3,1-benzoxazine Derivatives by Acid-Catalyzed Cyclizationof 2-Isocyanophenyl Ketones in the Presence of a Vinyl Ether

Kazuhiro Kobayashi, Yuta Okamura, Hisatoshi Konishi · Synthesis · 2009 · 27 citations

Visceral adipose tissue-derived serine protease inhibitor prevents the development of monocrotaline-induced pulmonary arterial hypertension in rats

Yuzaburo Sakamoto, Satoshi Kameshima, Chiharu Kakuda et al. · Pflügers Archiv - European Journal of Physiology · 2017 · 23 citations

Metabolic Syndrome, Hypertension, Pulmonary Arterial Hypertension +10

Vasculo-protective effect of BMS-309403 is independent of its specific inhibition of fatty acid-binding protein 4

Yuta Okamura, Kosuke Otani, Akihiro Sekiguchi et al. · Pflügers Archiv - European Journal of Physiology · 2017 · 20 citations

Inflammation, Specific Inhibition, Molecular Physiology +11

Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy

Yuichi Tambo, Yukio Hosomi, Hiroshi Sakai et al. · Investigational New Drugs · 2017 · 15 citations

Phase I/ii Study, Medicine, Pharmacology +7